Electronically facilitated transdermal delivery of human parathyroid hormone (1-34)

被引:36
作者
Medi, BA [1 ]
Singh, J [1 ]
机构
[1] N Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Fargo, ND 58102 USA
关键词
transdermal drug delivery; electroporation; iontophoresis; hPTH (1-34); porcine skin;
D O I
10.1016/S0378-5173(03)00337-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Electronically facilitated transdermal delivery of human parathyroid hormone (1-34), hPTH (1-34), was investigated in vitro, using dermatomed porcine skin. The effect of iontophoretic current density,electroporative pulse voltages and also electroporation followed by iontophoresis was investigated on the in vitro percutaneous absorption of hPTH (1-34). Iontophoresis at 0.5 mA/cm(2) Current density significantly enhanced (P < 0.05) the flux of hPTH (1-34) in comparison to passive flux. Electroporation pulses of 100, 200 and 300 V significantly increased (P < 0.05) the flux of hPTH (1-34) in comparison with the passive as well as iontophoretic flux at 0.5 mA/cm(2). The electroporative flux of hPTH (1-34) was found to vary linearly (R-2 = 0.97) with the pulse amplitude. The principal barrier of the skin, stratum corneum, was found perturbed following the pulses as evident by light microscopy studies. The application of electroporation pulses followed by iontophoresis further increased the flux by several fold. The flux of hPTH (1-34) with the electroporation Pulses Of 100 and 300V followed by iontophoresis at 0.2 mA/cm(2) was 10- and 5-fold higher, respectively, in comparison to the flux with corresponding pulses alone. This shows the synergistic effect of iontophoresis in combination with electroporation on skin permeability of hPTH (1-34). The results indicate the possibility of designing controlled transdermal delivery systems for hPTH (1-34) using electroporation followed by iontophoresis. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 14 条
  • [1] COMPARISON OF THE EFFECTS OF INTERMITTENT AND CONTINUOUS ADMINISTRATION OF HUMAN PARATHYROID HORMONE(1-34) ON RAT BONE
    UZAWA, T
    HORI, M
    EJIRI, S
    OZAWA, H
    BONE, 1995, 16 (04) : 477 - 484
  • [2] Pharmacokinetics and hepatic extraction of recombinant human parathyroid hormone, hPTH (1-34), in rat, dog, and monkey
    Jones, Karen O.
    Owusu-Ababio, Godfried
    Vick, Andrew M.
    Khan, M. Amin
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (11) : 2499 - 2506
  • [3] EFFECT OF INTERMITTENT ADMINISTRATION OF HUMAN PARATHYROID HORMONE(1-34) ON EXPERIMENTAL OSTEOPENIA OF RATS INDUCED BY OVARIECTOMY
    TAKAHASHI, HE
    TANIZAWA, T
    HORI, M
    UZAWA, T
    CELLS AND MATERIALS, 1991, : 113 - 117
  • [4] Transdermal delivery of human epidermal growth factor facilitated by a peptide chaperon
    Ruan, Ren-quan
    Wang, Shan-shan
    Wang, Chang-li
    Zhang, Li
    Zhang, Yun-jiao
    Zhou, Wei
    Ding, Wei-ping
    Jin, Pei-pei
    Wei, Peng-fei
    Man, Na
    Wen, Long-ping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 : 405 - 409
  • [5] Human Parathyroid Hormone (1-34) accelerates skin wound healing through inducing cell migration via up-regulating the expression of Rac1
    Sun, Qingpeng
    Zhou, Liya
    Yu, Zhiyong
    Zhang, Jun
    Zhang, Chao
    Pi, Honglin
    CELL DIVISION, 2024, 19 (01)
  • [6] Transdermal delivery of human growth hormone through RF-microchannels
    Levin, G
    Gershonowitz, A
    Sacks, H
    Stern, M
    Sherman, A
    Rudaev, S
    Zivin, I
    Phillip, M
    PHARMACEUTICAL RESEARCH, 2005, 22 (04) : 550 - 555
  • [7] Transdermal Delivery of Human Growth Hormone Through RF-Microchannels
    Galit Levin
    Amikam Gershonowitz
    Hagit Sacks
    Meir Stern
    Amir Sherman
    Sergey Rudaev
    Inna Zivin
    Moshe Phillip
    Pharmaceutical Research, 2005, 22 : 550 - 555
  • [8] Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration
    Kimura, S.
    Saito, M.
    Kida, Y.
    Seki, A.
    Isaka, Y.
    Marumo, K.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (03) : 1109 - 1119
  • [9] Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration
    S. Kimura
    M. Saito
    Y. Kida
    A. Seki
    Y. Isaka
    K. Marumo
    Osteoporosis International, 2017, 28 : 1109 - 1119
  • [10] Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1--34)
    Suzuki, Y
    Nagase, Y
    Iga, K
    Kawase, M
    Oka, M
    Yanai, S
    Matsumoto, Y
    Nakagawa, S
    Fukuda, T
    Adachi, H
    Higo, N
    Ogawa, Y
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (02) : 350 - 361